BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Nestle SA Purchase of Pfizer Inc. (PFE) Unit Blocked in Mexico


11/21/2012 8:07:11 AM

Nestle SA (NESN)’s acquisition of Pfizer Inc. (PFE)’s infant-nutrition unit in Mexico was blocked by the nation’s antitrust agency, which said the deal would hurt consumers. The transaction, part of an $11.9 billion deal to buy Pfizer’s worldwide nutrition business, would give Vevey, Switzerland-based Nestle market share of as much as 88 percent, depending on the type of baby formula, the agency said today in a statement. That would lead to price increases of as much as 11.5 percent, it said. The setback for Nestle may force the company to seek a buyer such as Danone SA for some assets, said Jon Cox, head of Swiss research at Kepler Capital Markets in Zurich. Nestle and New York-based Pfizer can also file an appeal within 30 business days, the antitrust agency said. “Danone (BN) is obviously very interested in those parts that can’t be part of the deal for regulatory reasons,” Cox said in an e-mail. “Nestle might be reluctant to sell to Danone as it is obviously a tough competitor in the segment on a global basis.”


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->